Nov23 M1-Pharmacology Antiplatelet Drugs Flashcards

1
Q

3 drug groups

A
  • inhibit Tx synthesis
  • block ADP receptor
  • inhibit glycoprotein IIB-IIIA
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
2
Q

use of anti-platelet drugs

A

prevent thrombosis

alter evolution of ats

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
3
Q

2 types of granules found in platelets

A
delta granules (contain ADP)
alpha granules
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
4
Q

mechanism of primary plug formation

A
  1. plts recon vWF and collagen and are activate
  2. activate plts release ADP, TxA2 and 5HT
  3. these substances activate platelets and activate an integrin (glycoprot IIB-IIIA) on their surface
  4. this integrin binds fibrinogen and fibrin
  5. formation of formalin aggregate
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
5
Q

what happens to plts when activated

A

change shape and have processes

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
6
Q

aspirin action

A

blocks covalently (irreversibly) COX-1 (acetylates serine residue near its active site) so can’t produce TxA2

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
7
Q

why aspirin effect irreversible

A

platelet no nucleus, can’T prod new COX 1

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
8
Q

why ASA less effective at higher dose (NSAID dose)

A

Also inhibits prostacyclin prod (prostacyclin is an endogenous anti platelet)

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
9
Q

where ASA absorbed

A

stomach and upper SI

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
10
Q

ASA overdose effect

A

primary metab pathway saturated. elim becomes order 0 (constant rate no matter dose). significant increase in plasma ASA

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
11
Q

aspirin effect on bleeding time

A

prolonged in all patients

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
12
Q

salicylism def + cause

A

reduce hearing, ringing in ears, dizziness. cause: mild overdose.

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
13
Q

aspirin use

A

secondary prevention of cerebral and cardiac ischemia, MI, …

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
14
Q

inhibitors of ADP pathway mechanism

A

block ADP receptor on platelet surface

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
15
Q

inhibitors of ADP pathway: give drugs

A

clopidogrel, prasugrel, ticagrelor

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
16
Q

diff between inhibitors of ADP pathway and ASA

A

they have no effect on PG metabolism

17
Q

2 inhibitors of ADP pathway used and effect

A

clopidogrel, prasugrel. irreversibly block ADP receptor

18
Q

how ADP activates platelets

A

binds two purine receptors. P2Y1 and P2Y12. both must be activated

19
Q

clopidogrel effect

A

irreversibly blocks P2Y12 receptor

20
Q

clopidogrel pharmacokinetics

A

given as prodrug, activated by enzymes in cytochrome P450.

21
Q

why clopidogrel resistance exists

A

genetic variability. some patients have reduced fct variant of CYP2C19 enzyme of the cytochrome P450

22
Q

when clopidogrel used with ASA and when used instead of ASA

A

clopidogrel in stroke

clopidogrel with aspirin in ACS (acute coronary syndrome)

23
Q

prasugrel effect + diff with clopidogrel

A

same effect. P2Y12 blocker irreversibly.

less resistance to it

24
Q

ticagrelor mechanism

A

blocks REVERSIBLY P2Y12

25
ticagrelor when
in ACS, to reduce CV death, MI and stroke (better than clopidogrel)
26
glycoprot IIB-IIIA fct
receptor fo fibrinogen and vWF
27
glycoprot IIB-IIIA inhibitors: potency and administration
best anti plt but replaced by ticagrelor and prasugrel | given by injection
28
abciximab charact and mechanism
Fab fragment of humanize monoclonal Ab against the receptor
29
eptifibatide and tirofiban mechanism
peptide (2nd is small molecule) blocker of fibrinogen binding site on the receptor
30
major side effect of glycoprot IIB-IIIA inhibitors
bleeding and thrombocytopenia
31
arterial vs venous side choice of medication
arterial side: anti platelet drug
32
which for stroke
``` anti platelet (clopidogrel) dabigatran ```
33
which for DVT
UF heparin and then warfarin | LMWH heparin if good kidney function and then warfarin
34
which prevention of cereb or cardiac and ischemia + MI
aspirin
35
which to prevent stroke if prosthetic heart valve or mitral stenosis
warfarin
36
which to prevent stroke in a fib
rivaroxaban
37
which for 6 hours after after acute STEMI
alteplase or tenecteplase